Crossmark

High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification

Crossref DOI link: https://doi.org/10.1186/s13073-021-00922-x

Published Online: 2021-07-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Olbrecht, Siel https://orcid.org/0000-0001-9452-5905
Busschaert, Pieter

Qian, Junbin

Vanderstichele, Adriaan

Loverix, Liselore

Van Gorp, Toon

Van Nieuwenhuysen, Els

Han, Sileny

Van den Broeck, Annick

Coosemans, An

Van Rompuy, Anne-Sophie

Lambrechts, Diether

Vergote, Ignace
Funding

Funding for this research was provided by:

Stichting Tegen Kanker (2018-133)
License Information

Text and Data Mining valid from 2021-07-09

Version of Record valid from 2021-07-09
More Information

Article History

Received: 6 May 2020

Accepted: 8 June 2021

First Online: 9 July 2021

Declarations

:

: The study was conducted in accordance with the Declaration of Helsinki and in accordance with the IGH-GHP principles (International Conference of Harmonisation Guidelines on Good Clinical Practice) and was approved by the Ethics Committee Leuven (University Hospitals Leuven, Belgium; ML2524/2013). Samples were taken after patients gave their written informed consent.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below